1. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Issue 10326 (19th February 2022) Authors: Heier, Jeffrey S; Khanani, Arshad M; Quezada Ruiz, Carlos; Basu, Karen; Ferrone, Philip J; Brittain, Christopher; Figueroa, Marta S; Lin, Hugh; Holz, Frank G; Patel, Vaibhavi; Lai, Timothy Y Y; Silverman, David; Regillo, Carl; Swaminathan, Balakumar; Viola, Francesco; Cheung, Chui Ming Gemmy; Won... Journal: Lancet Issue: Volume 399:Issue 10326(2022) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Standardization of Nomenclature for Ocular Tuberculosis – Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop. (30th September 2020) Authors: Agrawal, Rupesh; Agarwal, Aniruddha; Jabs, Douglas A.; Kee, Aera; Testi, Ilaria; Mahajan, Sarakshi; McCluskey, Peter J.; Gupta, Amod; Palestine, Alan; Denniston, Alastair; Banker, Alay; Invernizzi, Alessandro; Fonollosa, Alex; Sharma, Aman; Kumar, Amitabh; Curi, Andre; Okada, Annabelle; Schlaen, ... Journal: Ocular immunology and inflammation Issue: Volume 28:Number 1(2020) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗